Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm I: Introduction01:30

Aneurysm I: Introduction

562
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
562
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

955
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
955
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

449
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
449
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

414
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
414
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

714
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
714

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebrovascular vulnerability and fibrosis in human brain aneurysms.

Nature neuroscience·2026
Same author

Inositol Requiring Enzyme 1α Mediates Hypertension and Vascular Remodeling.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

A mouse model of hypertension induced by sucrose.

Hypertension research : official journal of the Japanese Society of Hypertension·2025
Same author

Ventral Midline Hysterectomy, Ovariectomy, and Ovariohysterectomy in Mus Musculus: A Surgical Protocol.

Scientific reports·2025
Same author

Glucose transporter 1 in vascular smooth muscle cells is dispensable for abdominal aortic aneurysm induced by angiotensin II.

JVS-vascular science·2025
Same author

Vascular Endothelial Growth Factor and the Pathogenesis of Intracranial Aneurysms: A Systematic Review on the Missing Link in a Complex Pathway.

Journal of the American Heart Association·2024

Related Experiment Video

Updated: Mar 6, 2026

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

20.9K

HIF1α in aortic aneurysms and beyond.

Tomoki Hashimoto1, Victor Rizzo2

  • 1Department of Anesthesia and Perioperative Care, Department of Neurological Surgery, University of California, San Francisco, U.S.A.

Clinical Science (London, England : 1979)
|March 18, 2017
PubMed
Summary

This study confirms myeloid cells contribute to abdominal aortic aneurysm (AAA) development. Hypoxia-inducible factor-1α (HIF1α) in these cells is crucial for regulating vessel wall weakening, offering potential therapeutic targets.

Keywords:
aneurysmhypoxia-inducible factorstranslational science

More Related Videos

Porcine Model of Infrarenal Abdominal Aortic Aneurysm
11:13

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

9.9K
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

856

Related Experiment Videos

Last Updated: Mar 6, 2026

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

20.9K
Porcine Model of Infrarenal Abdominal Aortic Aneurysm
11:13

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

9.9K
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

856

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Biology

Background:

  • Abdominal aortic aneurysm (AAA) is a life-threatening condition characterized by aortic wall expansion, often leading to rupture with high mortality.
  • Current treatment for AAA relies on surgical repair, highlighting the need for preventative and therapeutic strategies.
  • Understanding the cellular and molecular drivers of AAA is critical for developing novel interventions.

Purpose of the Study:

  • To investigate the role of myeloid cells in the pathogenesis of abdominal aortic aneurysm.
  • To elucidate the specific molecular mechanisms by which myeloid cells influence AAA development and progression.
  • To identify potential therapeutic targets within myeloid cell signaling pathways.

Main Methods:

  • Utilized a murine model of AAA to study the contribution of myeloid cells.
  • Investigated the role of hypoxia-inducible factor-1α (HIF1α) in myeloid cell function within the context of AAA.
  • Analyzed the expression of extracellular matrix (ECM) modifying enzymes and their inhibitors in myeloid cells.

Main Results:

  • Confirmed the significant contribution of myeloid cells to the development and progression of AAA.
  • Demonstrated that HIF1α is essential for regulating the expression of ECM-modifying enzymes and their inhibitors in myeloid cells.
  • Identified a critical link between HIF1α-mediated myeloid cell function and the degradation of the aortic vessel wall.

Conclusions:

  • Myeloid cells play a pivotal role in AAA formation and growth.
  • HIF1α is a key regulator of myeloid cell-induced extracellular matrix remodeling in AAA.
  • Targeting HIF1α in myeloid cells presents a promising therapeutic strategy to prevent or limit AAA progression.